Documents Estrogen and Coronary Heart Disease

Estrogen and Coronary Heart Disease by Brad Jones Case Presentation 56 y/o WF PMH significant for TAH on Premarin for 10 years. Cardiovascular risk factors include history…

Documents Study rationale and design

Study rationale and design EUROPA Study Investigators Lancet. 2003;362:782-788. ACE inhibition for secondary prevention of CAD Rationale Anti-atherosclerotic effects Plaque…

Documents Study rationale and design EUROPA Study Investigators Lancet. 2003;362:782-788.

Study rationale and design EUROPA Study Investigators Lancet. 2003;362:782-788. ACE inhibition for secondary prevention of CAD Rationale Anti-atherosclerotic effects Plaque…